๐ฐ Research Program News
Page 218 - Research Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Research Program. Real-time updates on events, politics, business and more.
January 9, 2022
A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine.
January 7, 2022
Study shows 'broader protection' from spike ferritin nanoparticle
January 7, 2022
Aston University collaborated with the worldโs first manufacturer of intraocular lenses (IOLs), Rayner Intraocular Lenses, to come up with the next generation of lenses that provide patients a high-quality full range of vision without the requirement of spectacles.
January 6, 2022
Helen Strongman and colleagues investigate the health and demographic factors associated with excess mortality during, as compared to before, the COVID-19 pandemic.
January 5, 2022
Two detection kits for mangoโs anthracnose and stem-end rot diseases have been developed, the Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development of the Department of Science and Technology (DOST-PCAARRD) announced. LAMP kits for detection of anthracnose and
January 5, 2022
The "Switzerland Power Market Outlook to 2030, Update 2021 Market Trends, Regulations, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. This report discusses
January 5, 2022
Carlos Del Rio is Rollins Professor and chair of the Hubert Department of Global Health. He also co-directs the Emory Center for AIDS Research and leads the Emory AIDS International Training and Research Program (AITRP).
December 27, 2021
The president of the Valencia Region, Ximo Puig, has highlighted that 94.53% of the Valencian population has already received the complete vaccination schedule, which means having immunised 4,242,773 people, with the first anniversary of the start of vaccination against COVID-19 in the Valencian Community. This was stated after holding a meeting with experts from โฆ
December 22, 2021
/PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...